Enzolytics

Enzolytics CapEx/D&A

CapEx to Depreciation Ratio of Enzolytics (ENZC) as of Oct 28, 2026.

CapEx/D&A

-

Last updated:

CapEx to Depreciation Ratio of Enzolytics is 2026 - . CapEx to Depreciation Ratio of Enzolytics was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enzolytics Stock analysis

What does Enzolytics do? Enzolytics Inc is an innovative biotechnology company specializing in the development of effective therapies for combating infectious diseases and cancer. Enzolytics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enzolytics stock

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio Enzolytics since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's Enzolytics with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Enzolytics

All Key Metrics — Enzolytics